Yüklüyor......
Dasatinib promotes TRAIL‐mediated apoptosis by upregulating CHOP‐dependent death receptor 5 in gastric cancer
Dasatinib, a tyrosine kinase inhibitor, has been approved for first‐line treatment of leukemia and has also been evaluated for use in numerous other cancers. However, its role in gastric cancer (GC) remains unclear. Therefore, the aim of this study was to investigate how dasatinib suppresses the gro...
Kaydedildi:
| Yayımlandı: | FEBS Open Bio |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
John Wiley and Sons Inc.
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5929929/ https://ncbi.nlm.nih.gov/pubmed/29744288 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/2211-5463.12404 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|